Efficacy and Safety of Wuling Capsule Combined with Fupentixol and Melitracen Tablets in Active Ulcerative Colitis Patients Accompanied with Anxiety and Depression

BackgroundPsychotherapy is an important component of the treatment program for inflammatory bowel disease (IBD) , a common chronic incurable digestive system disease accompanied with psychosomatic disorder, which involves ulcerative colitis (UC) . Wuling capsule has proven to be effective in multipl...

Full description

Bibliographic Details
Main Author: MO Dayu, LIU Yingchao, WANG Feida, NI Siyi, SHEN Yan
Format: Article
Language:zho
Published: Chinese General Practice Publishing House Co., Ltd 2022-01-01
Series:Zhongguo quanke yixue
Subjects:
Online Access:https://www.chinagp.net/fileup/1007-9572/PDF/1640773219135-954767626.pdf
_version_ 1827289939774013440
author MO Dayu, LIU Yingchao, WANG Feida, NI Siyi, SHEN Yan
author_facet MO Dayu, LIU Yingchao, WANG Feida, NI Siyi, SHEN Yan
author_sort MO Dayu, LIU Yingchao, WANG Feida, NI Siyi, SHEN Yan
collection DOAJ
description BackgroundPsychotherapy is an important component of the treatment program for inflammatory bowel disease (IBD) , a common chronic incurable digestive system disease accompanied with psychosomatic disorder, which involves ulcerative colitis (UC) . Wuling capsule has proven to be effective in multiple gastrointestinal diseases with psychosomatic disorders, but there are rare studies about its effect on improving the condition, anxiety and depression of UC patients.ObjectiveTo investigate the efficacy and safety of Wuling capsule with Fupentixol and melitracen tablets in active UC patients with anxiety and depression.MethodsA total of 120 active UC patients with anxiety and depression were selected from Gastroenterology Clinic or Inpatient Department of the Second Affiliated Hospital of Zhejiang Chinese Medical University and Zhejiang Provincial Tongde Hospital from January 2019 to December 2020, and equally, double-blindly randomized into control group, Deanxit group, Wuling capsule group and combination group, receiving Mesalazine sustained-release tablets (hereinafter referred to Mesalazine) , Mesalazine with Fupentixol and melitracen tablets, Mesalazine with Wuling capsules, Mesalazine with Fupentixol and melitracen tablets and Wuling capsules, respectively. All of the four groups were treated for 8 consecutive weeks as a course. Pre- and post-treatment main clinical symptom score, modified Mayo score, inflammatory response indicators, Zung Self-rating Anxiety Scale (SAS) score, Zung Self-rating Depression Scale (SDS) score, and Inflammatory Bowel Disease Questionnaire (IBDQ) score were compared across the four groups. Meanwhile, safety evaluation for the four treatments was conducted.ResultsFinally, 113 cases (except Wuling capsule group containing 29 cases, other three groups containing 28 cases) who completed this study were included for analysis. Compared with other three groups, combination group showed lower post-treatment diarrhea score, mucus with blood and pus in stools score, abdominal pain score and total score of clinical symptoms, modified Mayo score, erythrocyte sedimentation rate, serum levels of C-reactive protein, tumor necrosis factor-α and interleukin-6, as well as SAS and SDS scores, and higher scores of bowel, systemic, emotional and social domains and total IBDQ score (P<0.05) . One control group case had abdominal distension and one Deanxit group case had hyposomnia during treatment, but were spontaneously relieved.ConclusionIn active UC patients accompanied with anxiety and depression, Wuling capsule with Fupentixol and melitracen tablets could relieve the clinical symptoms, severity of condition, inflammatory response, anxiety and depression disorders, improve the quality of life, with relatively high safety. Therefore, Wuling capsule may be a choice for optimizing the comprehensive treatment plan of UC.
first_indexed 2024-04-24T11:59:34Z
format Article
id doaj.art-3d69ca986952423f9b269f8740fb6643
institution Directory Open Access Journal
issn 1007-9572
language zho
last_indexed 2024-04-24T11:59:34Z
publishDate 2022-01-01
publisher Chinese General Practice Publishing House Co., Ltd
record_format Article
series Zhongguo quanke yixue
spelling doaj.art-3d69ca986952423f9b269f8740fb66432024-04-09T02:50:00ZzhoChinese General Practice Publishing House Co., LtdZhongguo quanke yixue1007-95722022-01-01250328529210.12114/j.issn.1007-9572.2021.02.067Efficacy and Safety of Wuling Capsule Combined with Fupentixol and Melitracen Tablets in Active Ulcerative Colitis Patients Accompanied with Anxiety and DepressionMO Dayu, LIU Yingchao, WANG Feida, NI Siyi, SHEN Yan0 1.Education Department,the Second Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310005,China 2.Zhejiang Chinese Medical University,Hangzhou 310053,China 3.Deportment of TCM,Zhejiang Provincial Tongde Hospital,Hangzhou 310012,China 4.Department of Gastroenterology,the Second Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310005,China *Corresponding author:SHEN Yan,Associate chief physician;E-mail:shendanxi61115@163.com BackgroundPsychotherapy is an important component of the treatment program for inflammatory bowel disease (IBD) , a common chronic incurable digestive system disease accompanied with psychosomatic disorder, which involves ulcerative colitis (UC) . Wuling capsule has proven to be effective in multiple gastrointestinal diseases with psychosomatic disorders, but there are rare studies about its effect on improving the condition, anxiety and depression of UC patients.ObjectiveTo investigate the efficacy and safety of Wuling capsule with Fupentixol and melitracen tablets in active UC patients with anxiety and depression.MethodsA total of 120 active UC patients with anxiety and depression were selected from Gastroenterology Clinic or Inpatient Department of the Second Affiliated Hospital of Zhejiang Chinese Medical University and Zhejiang Provincial Tongde Hospital from January 2019 to December 2020, and equally, double-blindly randomized into control group, Deanxit group, Wuling capsule group and combination group, receiving Mesalazine sustained-release tablets (hereinafter referred to Mesalazine) , Mesalazine with Fupentixol and melitracen tablets, Mesalazine with Wuling capsules, Mesalazine with Fupentixol and melitracen tablets and Wuling capsules, respectively. All of the four groups were treated for 8 consecutive weeks as a course. Pre- and post-treatment main clinical symptom score, modified Mayo score, inflammatory response indicators, Zung Self-rating Anxiety Scale (SAS) score, Zung Self-rating Depression Scale (SDS) score, and Inflammatory Bowel Disease Questionnaire (IBDQ) score were compared across the four groups. Meanwhile, safety evaluation for the four treatments was conducted.ResultsFinally, 113 cases (except Wuling capsule group containing 29 cases, other three groups containing 28 cases) who completed this study were included for analysis. Compared with other three groups, combination group showed lower post-treatment diarrhea score, mucus with blood and pus in stools score, abdominal pain score and total score of clinical symptoms, modified Mayo score, erythrocyte sedimentation rate, serum levels of C-reactive protein, tumor necrosis factor-α and interleukin-6, as well as SAS and SDS scores, and higher scores of bowel, systemic, emotional and social domains and total IBDQ score (P<0.05) . One control group case had abdominal distension and one Deanxit group case had hyposomnia during treatment, but were spontaneously relieved.ConclusionIn active UC patients accompanied with anxiety and depression, Wuling capsule with Fupentixol and melitracen tablets could relieve the clinical symptoms, severity of condition, inflammatory response, anxiety and depression disorders, improve the quality of life, with relatively high safety. Therefore, Wuling capsule may be a choice for optimizing the comprehensive treatment plan of UC.https://www.chinagp.net/fileup/1007-9572/PDF/1640773219135-954767626.pdf|colitis, ulcerative|wuling capsule|fupentixol and melitracen tablets|mood disorder|anxiety|depression|quality of life|treatment outcome
spellingShingle MO Dayu, LIU Yingchao, WANG Feida, NI Siyi, SHEN Yan
Efficacy and Safety of Wuling Capsule Combined with Fupentixol and Melitracen Tablets in Active Ulcerative Colitis Patients Accompanied with Anxiety and Depression
Zhongguo quanke yixue
|colitis, ulcerative|wuling capsule|fupentixol and melitracen tablets|mood disorder|anxiety|depression|quality of life|treatment outcome
title Efficacy and Safety of Wuling Capsule Combined with Fupentixol and Melitracen Tablets in Active Ulcerative Colitis Patients Accompanied with Anxiety and Depression
title_full Efficacy and Safety of Wuling Capsule Combined with Fupentixol and Melitracen Tablets in Active Ulcerative Colitis Patients Accompanied with Anxiety and Depression
title_fullStr Efficacy and Safety of Wuling Capsule Combined with Fupentixol and Melitracen Tablets in Active Ulcerative Colitis Patients Accompanied with Anxiety and Depression
title_full_unstemmed Efficacy and Safety of Wuling Capsule Combined with Fupentixol and Melitracen Tablets in Active Ulcerative Colitis Patients Accompanied with Anxiety and Depression
title_short Efficacy and Safety of Wuling Capsule Combined with Fupentixol and Melitracen Tablets in Active Ulcerative Colitis Patients Accompanied with Anxiety and Depression
title_sort efficacy and safety of wuling capsule combined with fupentixol and melitracen tablets in active ulcerative colitis patients accompanied with anxiety and depression
topic |colitis, ulcerative|wuling capsule|fupentixol and melitracen tablets|mood disorder|anxiety|depression|quality of life|treatment outcome
url https://www.chinagp.net/fileup/1007-9572/PDF/1640773219135-954767626.pdf
work_keys_str_mv AT modayuliuyingchaowangfeidanisiyishenyan efficacyandsafetyofwulingcapsulecombinedwithfupentixolandmelitracentabletsinactiveulcerativecolitispatientsaccompaniedwithanxietyanddepression